Document is current
Any future updates will be listed below
-
Authors
Chen, Shuang
Ho, Tina
Asubonteng, Julius
Sobel, Rachel E.
Eng, Simon
DiMartino, Stephen J.
Manthripragada, Angelika
- License Information
-
More Information
Article History
Received: 8 January 2024
Accepted: 19 April 2024
First Online: 15 June 2024
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and the Health Insurance Portability and Accountability Act. Institutional review board approval was not required as the study used de-identified secondary data.
: Not applicable.
: All authors are Regeneron Pharmaceuticals, Inc. employees/shareholders. R.E.S is also a stockholder of Pfizer Inc.
